How come you are no longer talking about what you believe is the amazing life saving effects of ivermectin in India?
Is that because studies in India have shown that ivermectin has little or no effect on COVID?
First, look at the date on this link: September 26, 2021. This old news.
From the first post in this forum, we know that some jurisdictions in India endorsed Ivermectin, and some did not. So, it is not surprising that some authoritative body in India at that time would publicly state reasons why they oppose the use of Ivermectin to treat Covid. Similar con and pro documents have been published around the world before and after this one.
From the linked article: “Recommending that Ivermectin be dropped from the clinical guidance, experts cited 13 systematic reviews of which “7/13 showed mortality benefit, 4/13 no mortality benefit, 2/13 inconclusive/unclear.””
So, there is no claim of any new results from Ivermectin use in India. There is no claim that any of the studies reviewed pertain to data gathered in India at all. They just looked at systematic reviews that existed at the time. i.e., the same data everyone else has looked at with ongoing controversy. Even then, the majority showed a mortality benefit. The logical conclusion from the 7/4/2 breakdown is at worst, inconclusive.
The article goes on, apparently recognizing that readers might wonder why the 4 negative and 2 inconclusive studies should outweigh the 7 positive results: “Additionally, there was a high risk of bias in many of the studies, particularly with the ones showing mortality benefit, as the level of certainty is low in them.” It is not clear whether “the studies” refers to the 13 systematic reviews, or the studies that were reviewed therein. Since we do not have access to the original report, we have no idea which studies were deemed to have a high risk of bias, or why. Systematic reviewers have tools to detect risk of bias, but different reviewers still can reach opposite conclusions about particular studies. It seems that a determination of risk of bias can itself carry a risk of bias.
We do know that at least one influential systematic review had its conclusions altered by powerful moneyed interests opposed to ivermectin. This was discussed at length in a series of posts in the “COVID treatments debate forum: here, here here and here.